All Stories

  1. High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease
  2. Hepatocellular Carcinoma Intermediate Stage Subclassification Systems: One, None, and One Hundred Thousand
  3. Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: The perfect storm
  4. Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases
  5. Metabolic disorders across hepatocellular carcinoma in Italy
  6. Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn
  7. Specific issues concerning the management of patients on the waiting list and after liver transplantation
  8. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
  9. Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma
  10. Noninvasive assessment of varices needing treatment in patients with advanced chronic liver disease: No one should be left behind
  11. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
  12. Breath Tests to Assess Alcoholic Liver Disease
  13. Hepatobiliary and Pancreatic: A rare cause of portal hypertension
  14. Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy
  15. Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see
  16. Platelet Dysfunction: Status of Thrombopoietin in Thrombocytopenia Associated with Chronic Liver Failure
  17. Optimal management of constipation associated with irritable bowel syndrome
  18. Use of Liver Breath Tests to Assess Severity of Nonalcoholic Fatty Liver Disease
  19. Prognosis of untreated hepatocellular carcinoma
  20. Prognostic Prediction and Identification of Candidates for Salvage Liver Transplantation Among Patients With Early Hepatocellular Carcinoma
  21. Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care
  22. Correction of hemostatic abnormalities and portal pressure variations in patients with cirrhosis
  23. Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use
  24. Platelet count and survival of patients with compensated cirrhosis and small hepatocellular carcinoma treated with surgery